Cases & Deals

  • Home
  • Practices
  • BioMarin establishes global patent portfolio for PAL technology

Share

BioMarin establishes global patent portfolio for PAL technology

September 2008

Client(s) BioMarin Pharmaceutical, Inc.

On behalf of BioMarin Pharmaceutical, Inc., Jones Day assisted with global patent portfolio development and prosecution strategies regarding Prokaryotic Phenylalanine Ammonia-Lyase (PAL).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.